8-羟基-delta(9)-四氢大麻酚 | 38456-07-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 中文名称: 8-羟基-delta(9)-四氢大麻酚
• 英文名称: 8-Hydroxy-delta(9)-tetrahydrocannabinol
• 英文别名: (6aR,8R,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-1,8-diol
• CAS: 38456-07-4；34984-78-6
• 化学式: C₂₁H₃₀O₃
• 分子量: 330.5
• InChiKey: INKUWBOHCFHXTJ-BRWVUGGUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF
  申请人：CALIFORNIA AMBER INC.

  公开号：US20210068444A1

  公开（公告）日：2021-03-11

  Provided herein are compositions comprising cannabinoids, terpenoids, and other flavonoids. Also provided herein are methods for producing compositions comprising cannabinoids, terpenoids, and other flavonoids at industrial scale. In certain embodiments, the compositions provided herein possess desirable organoleptic properties and therapeutic effects when ingested or topically applied. In certain embodiments, the compositions of the present disclosure have are useful in inhalable, ingestible, or topical products to relieve and treat various acute or chronic illnesses.
• [EN] SYSTEMS AND METHODS FOR PREPARING CANNABINOIDS AND DERIVATIVES<br/>[FR] SYSTÈMES ET PROCÉDÉS DE PRÉPARATION DE CANNABINOÏDES ET DE DÉRIVÉS
  申请人：LYGOS INC

  公开号：WO2021042057A1

  公开（公告）日：2021-03-04

  Provided herein are systems and methods for the production of cannabinoid derivatives in host cells, such as e.g., those containing or utilizing OLS and other enzymes provided or utilized herein. As used herein, cannabinoids include olivetol; olivetolic acid; olivetolic acid derived compounds obtainable according to the enzymatic transformations of the cannabinoid pathway such as that shown in Figure 1; compounds of formula (I); compounds of formula (I) chemically transformed according to the enzymatic transformations of the cannabinoid pathway such as that shown in Figure 1; and the likes.
• [EN] CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF<br/>[FR] COMPOSITIONS DE CANNABINOÏDES À PROPRIÉTÉS ORGANOLEPTIQUES ET THÉRAPEUTIQUES AMÉLIORÉES, LEUR PROCÉDÉ DE PRODUCTION ET LEUR UTILISATION
  申请人：CALIFORNIA AMBER INC

  公开号：WO2021050786A1

  公开（公告）日：2021-03-18

  Provided herein are compositions comprising cannabinoids, terpenoids, and other flavonoids. Also provided herein are methods for producing compositions comprising cannabinoids, terpenoids, and other flavonoids at industrial scale. In certain embodiments, the compositions provided herein possess desirable organoleptic properties and therapeutic effects when ingested or topically applied. In certain embodiments, the compositions of the present disclosure have are useful in inhalable, ingestible, or topical products to relieve and treat various acute or chronic illnesses.
• [EN] CANNABINOID COMPOSITIONS<br/>[FR] COMPOSITIONS DE CANNABINOÏDES
  申请人：THE QUEENS MEDICAL CENTER

  公开号：WO2021188983A1

  公开（公告）日：2021-09-23

  Described herein are pharmaceutical compositions comprising cannabinoids. In some embodiments, such compositions are useful for the treatment of inflammatory, autoimmune diseases or disorders, cancer, or neurodegenerative diseases. Further provided herein are pharmaceutical compositions comprising combinations of cannabinoids possessing entourage effects.